Diabetes Drugs Unexpectedly Raise Levels of Gut Microbe-Linked Heart Risk Marker TMAO
A pooled analysis of two placebo-controlled crossover trials shows that the SGLT-2 inhibitors empagliflozin and dapagliflozin modestly but significantly raise ...
Tag: SGLT-2 inhibitors
Popular Diabetes Drugs Show No Effect on Thyroid Hormone or Inflammation Markers
A retrospective study of 330 patients with type 2 diabetes found that long-term use of SGLT-2 inhibitors empagliflozin and dapagliflozin ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!